Abstract
The results presented above relate to several aspects of the 2-5A system. A simple but insensitive radiochemical assay fro 2-5A and its synthetase is described. Progress towards the molecular characterization of the synthetase suggested that it is composed of a single 56,000 dalton polypeptide chain that is synthesized in response to IF treatment. Degradation of 2-5A occurs at the same rapid rate in extracts of IF-treated and untreated chick cells. However, this breakdown can be inhibited by its end-product, 5'AMP, or by the activated synthetase which can further elongate 2-5A and thereby protect it from degradation. The direction of elongation is from the 5' to the 2' terminus. Molecules other than 2-5A can act as substrates fro 2'-adenylation by the activated synthetase. These include some dinucleoside monophosphates, ADP-ribose and NAD+, and methylene-bridged analogues of ATP. The methylene-bridged analogues of 2-5A that are synthesized in the latter case retain some of the biological activity of authentic 2-5A, indicating that cleavage of the 5'-terminal phosphate group(s) is not involved in the mechanism of nuclease activation by 2-5A.
References
Jul 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·A G HovanessianL Montagnier
Feb 1, 1978·Virology·L A Ball, C N White
Dec 1, 1978·European Journal of Biochemistry·B R WilliamsL A Ball
May 1, 1979·Biochemistry·C BaglioniD K West
Mar 1, 1979·Virology·L A Ball, C N White
Sep 1, 1979·FEBS Letters·B R WilliamsI M Kerr
Jul 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·A KimchiM Revel
Oct 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·A SchmidtM Revel
Jan 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·I M Kerr, R E Brown
Mar 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·L A Ball, C N White
Dec 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·P J FarrellP Lengyel
Jan 1, 1978·Annual Review of Biochemistry·M Revel, Y Groner
Mar 29, 1979·Nature·G R StarkI M Kerr
Apr 30, 1979·Virology·L A Ball
Jun 1, 1979·Cell·C Baglioni
Apr 2, 1979·European Journal of Biochemistry·E M MartinI M Kerr
Oct 15, 1979·Virology·D A EppsteinC E Samuel
Mar 1, 1978·Cell·M J Clemens, B R Williams
Nov 2, 1978·Nature·B R Williams, I M Kerr
Jul 5, 1974·Nature·I M KerrL A Ball
Apr 15, 1974·FEBS Letters·J ContentM Revel
Citations
Jan 1, 1984·Neurosurgical Review·M Nagai, T Arai
Oct 18, 1983·Biochimica Et Biophysica Acta·T J BorelliJ M Wu
Jun 12, 1998·Pharmacology & Therapeutics·M R Player, P F Torrence
Aug 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·M Etienne-SmekensJ E Dumont
Mar 25, 1982·Nucleic Acids Research·J L DrocourtM N Thang
Sep 1, 1982·European Journal of Biochemistry·M Verhaegen-Lewalle, J Content
Feb 17, 1986·European Journal of Biochemistry·M WatheletJ Content
Jan 30, 1984·FEBS Letters·S VilcekM Jurovcík
Jan 1, 1989·Annals of the New York Academy of Sciences·D OrlicC Sandoval
Jun 27, 2015·BMC Biochemistry·Jesper Buchhave PoulsenPia Møller Martensen
May 18, 1999·Virology·T V SharpM J Clemens
Nov 1, 1982·Molecular and Cellular Biology·D K West, L A Ball